DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ozagrel
Ozagrel
Prostaglandin D2 and the Role of the DP1, DP2 and TP Receptors in the Control of Airway Reflex Events
4 Supplementary File
Cyclooxygenase Pathway
Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr
Effect of TTC-909 on Cerebral Infarction Following Permanent Occlusion of the Middle Cerebral Artery in Stroke Prone Spontaneously Hypertensive Rats
Nicotine in High Concentration Causes Contraction of Isolated Strips of Rabbit Corpus Cavernosum
Jp Xvii the Japanese Pharmacopoeia
Multidrug Treatment with Nelfinavir and Cepharanthine Against COVID-19
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
The Efficacy of Ozagrel Sodium As a Rescue Or Prophylaxis in The
A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre- Clinical Discoveries
Ozagrel Hydrochloride, a Selective Thromboxane A2 Synthase Inhibitor
I in Un Torn Untuk Ta in an Atau Mana Na Anth
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Selective Inhibition of Prostaglandin D2 Biosynthesis in Human Mast Cells to Overcome Need for Multiple Receptor Antagonists: Biochemical Consequences
Anatomical Classification Guidelines V2020 EPHMRA ANATOMICAL
Harnessing DNA-Encoded Libraries to Discover Bioactive Small Molecules
Stembook 2018.Pdf
Top View
Relationship Between the Thromboxane A2 Receptor Gene and Susceptibility to Cerebral Infarction
WHO-EMP-RHT-TSN-2018.1-Eng.Pdf
Supplement Ii to the Japanese Pharmacopoeia Seventeenth Edition
Novel Modulation of Adenylyl Cyclase Type 2 Jason Michael Conley Purdue University
Ozagrel Hydrochloride Hydrate
FDA-Approved Drug Library Mini (96-Well)
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
(JP) Shall Be Established As Follows: 1. to Establ
The Japanese Pharmacopoeia Fifteenth Edition Shall Be Partially Amended As Follows:
Marrakesh Agreement Establishing the World Trade Organization
Anatomical Classification Guidelines V2018 EPHMRA ANATOMICAL
Drug-Induced Diseases
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
1873 JP XVI Infrared Reference Spectra
General Information
Drug-Resin Complexes Stabilized by Chelating Agents
The Inhibitory Effect of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) on the Monophenolase and Diphenolase Activities of Mushroom Tyrosinase
Changes Highlighted Final Version Date of Issue
Recent Progress and Market Analysis of Anticoagulant Drugs
A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
Recent Advances in the Development of Anti-Allergic Drugs Hiroichi Nagai1, Hitomi Teramachi1 and Teruo Tuchiya1
Community-Acquired Pneumonia: Pathogenesis of Acute Cardiac Events and Potential Adjunctive Therapies
Influence of Ozagrel Sodium Along Atypical Anti-Psychotic Drug on Red
A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule Xxi - 1
Supplementary Table 3
Known Bioactives Library: Prestwick 2 Collection
Comparison of the Therapeutic Efficacy of Ozagrel Alone and Ozagrel Plus Edaravone Therapy for Acute Ischemic Stroke Patients : a Prospective Study
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Rank Cmap Name 1 Trichostatin a 2 Piribedil 3 Omeprazole 4 MS-275 5 Penbutolol 6 Calcium Folinate 7 Phthalylsulfathiazole 8 Clop
Immune System, Inflammation, Allergy Research Reagents
Anti-Inflammatory Role of PGD2 in Acute Lung Inflammation and Therapeutic Application of Its Signal Enhancement
(19) United States (12) Patent Application Publication (10) Pub
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
(12) United States Patent (10) Patent No.: US 8,632,760 B2 Woodward Et Al
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
L-Arginine Supplementation and Thromboxane Synthase Inhibition Increases Cerebral Blood Flow in Experimental Cerebral Malaria
Pharmaceutical Appendix to the Tariff Schedule 2
T-Cell Activation-Inhibitory Assay to Screen Caloric Restriction Mimetics
Thromboxane Receptors Antagonists And/Or Synthase Inhibitors
WO 2012/123502 Al 20 September 2012 (20.09.2012) P O P C T
WO 2007/016766 Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances